2025-11-06 - Analysis Report
Okay, here's a report on Intuitive Surgical Inc. (ISRG), incorporating all the data you provided.

**Report on Intuitive Surgical Inc. (ISRG)**

**0. Executive Summary**

Intuitive Surgical (ISRG) shows strong historical outperformance compared to the S&P 500 (VOO), particularly when looking back several years. Recent performance has been more mixed, but positive indicators suggest continued upward momentum. Analyst ratings are generally favorable, and financial data points to robust revenue growth and profitability. However, the stock appears overbought in the short term, requiring careful monitoring.

**1. Relative Performance Analysis**

*   **Ticker:** ISRG
*   **Company:** Intuitive Surgical Inc.
*   **Description:** A company that designs, manufactures, and markets robotic products to improve clinical outcomes through minimally invasive surgery.
*   **ISRG Cumulative Return:** 101.78%
*   **VOO Cumulative Return:** 99.52%
*   **Divergence:**
    *   Current Difference: -3.0%
    *   Range: Max 98.9%, Min -37.8%
    *   Relative Divergence: 25.5%

**Analysis:** ISRG has outperformed VOO over the examined period, but the current difference is -3.0%, suggesting recent underperformance. The Relative Divergence of 25.5% indicates that while ISRG has historically shown significant outperformance, it is currently performing closer to the lower end of its historical range compared to the S&P 500.

*   **Alpha/Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta    | Cap(B) |
|------------|---------|---------|---------|---------|--------|
| 2015-2017  | 68.0%   | 77.6%   | 40.0%   | -0.1    | 43.1   |
| 2016-2018  | 64.0%   | 72.2%   | 49.0%   | -0.0    | 56.6   |
| 2017-2019  | 54.0%   | 72.2%   | 31.0%   | 0.2     | 69.8   |
| 2018-2020  | -6.0%   | 80.4%   | -29.0%  | 0.3     | 96.7   |
| 2019-2021  | 29.0%   | 80.4%   | -18.0%  | 0.6     | 127.3  |
| 2020-2022  | -23.0%  | 80.4%   | -22.0%  | 1.2     | 94.0   |
| 2021-2023  | -17.0%  | 77.5%   | -18.0%  | 1.7     | 119.6  |
| 2022-2024  | 36.0%   | 77.5%   | 15.0%   | 1.7     | 185.0  |
| 2023-2025  | 64.0%   | 72.7%   | 0.0%    | 0.8     | 192.7  |

**Analysis:** The table indicates a high CAGR and MDD with varying Alpha and Beta values. Earlier periods (2015-2019) show strong positive Alpha, indicating outperformance relative to its risk. More recent periods (2018-2023) show negative Alpha, suggesting underperformance. Beta has generally increased over time, meaning ISRG's price has become more sensitive to market movements.

**2. Recent Price Action**

*   **Current Price:** 543.76
*   **Last Market Data:**
    *   Price: 543.63
    *   Previous Close: 538.82
    *   Change: 0.89
*   **Moving Averages:**
    *   5-day: 537.97
    *   20-day: 491.31
    *   60-day: 468.45

**Analysis:** The stock price is currently above all three moving averages, suggesting a bullish trend. The recent price increase (change of 0.89) confirms this upward momentum.

**3. Technical Indicators & Outlook**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 83.16 (Overbought)
*   **PPO:** 0.9469
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-11-03)
*   **Delta_Previous_Relative_Divergence (20-day):** 17.4 (+) (Short-term Increase)
*   **Expected Return:** 35.6% (Long-term, vs. S&P 500)

**Analysis:**

*   The high RSI value suggests the stock is overbought and may be due for a correction.
*   The MRI indicates a generally favorable investment environment.
*   The positive change in relative divergence indicates strong recent performance.
*   The "change" of 0.89 from the previous close reflects a continued positive trend.
*   The Expected Return suggests a potentially significant outperformance over the S&P 500 in the long term (2+ years).

**4. Recent News & Significant Events (Yahoo Finance):**

*   **Positive Catalysts:** Several articles highlight Intuitive Surgical's strong prospects, including its position in the Nasdaq 100 and reasons to watch the stock. The "IBD Stock Of The Day" article further reinforces this positive outlook.
*   **Investor Concerns:** One article mentions investor concerns leading to a price decrease, potentially related to valuation or broader market concerns.
*   **Value Comparison:** One article compares ISRG to another stock (ALC) in terms of value, suggesting ongoing discussions about its valuation.

**Analysis:** The news flow is generally positive, with several articles emphasizing the company's strengths and growth potential. However, the mention of investor concerns and valuation discussions suggests the market is carefully evaluating the stock's price relative to its fundamentals.

**4-2) Analyst Opinions (consensus / targets / recent changes):**

*   **Consensus:** Buy (~1.97 on a 1-5 scale)
*   **Target Price:**
    *   Average: 593.06
    *   High: 700.00
    *   Low: 378.00
*   **Recent Rating Changes:** No data provided, so unable to perform analysis

**Analysis:** Analyst consensus leans towards a "Buy" rating. The average target price suggests potential upside from the current price. However, the wide range between high and low target prices indicates uncertainty among analysts.

**5. Recent Earnings Analysis:**

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-10-22 | 1.98 | 2.51 B$   |
| 2025-07-23 | 1.84 | 2.44 B$   |
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2025-10-22 | 1.59 | 2.04 B$   |

**Analysis:** The earnings data shows consistent growth in both EPS and Revenue over the recent quarters. This indicates the company is performing well financially and meeting or exceeding expectations.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | $2.44B   | 66.31%        |
| 2025-03-31 | $2.25B   | 64.69%        |
| 2024-12-31 | $2.41B   | 68.04%        |
| 2024-09-30 | $2.04B   | 67.41%        |
| 2024-06-30 | $2.01B   | 68.30%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-06-30 | $17.85B  | 3.69%   |
| 2025-03-31 | $17.11B  | 4.08%   |
| 2024-12-31 | $16.43B  | 4.17%   |
| 2024-09-30 | $15.58B  | 3.63%   |
| 2024-06-30 | $14.71B  | 3.58%   |

**Analysis:**

*   **Revenue & Profitability:** Revenue shows a general upward trend, indicating strong sales growth. High and consistent profit margins confirm the company's ability to generate profits efficiently.
*   **Capital & Profitability:** Equity has steadily increased, showing financial stability and growth. ROE fluctuates but remains within a healthy range, demonstrating efficient use of shareholder equity to generate profits.

**7. Comprehensive Analysis Summary**

*   **Positive Aspects:** ISRG demonstrates robust financial performance, as evidenced by increasing revenue, high-profit margins, and growing equity. Analyst consensus is generally positive, with a "Buy" rating and an average target price suggesting potential upside. Long-term growth prospects, as indicated by the expected return, are promising.
*   **Concerning Aspects:** The high RSI indicates that the stock is overbought and may be due for a correction. Recent performance has shown underperformance compared to the S&P 500, but the Delta_Previous_Relative_Divergence (20-day) shows promise. The article referencing investor concerns and valuation suggests that investors must be cautious and monitor the stock closely.
*   **Recommendation:** Given the company's strong financial performance, positive analyst sentiment, and long-term growth potential, ISRG is a promising investment. However, the high RSI and recent underperformance suggest that a cautious approach is warranted. Investors should monitor the stock closely for potential correction signals and consider waiting for a pullback before initiating or adding to positions. It will be more prudent to continue buying the stock.

**Disclaimer:** *This analysis is based on the provided data and should not be considered financial advice. Investors should conduct their own research and consult with a financial advisor before making any investment decisions.*
